Gilead Sciences Stock Buy Hold or Sell Recommendation

GILD Stock  USD 67.31  0.44  0.65%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Gilead Sciences is 'Strong Hold'. Macroaxis provides Gilead Sciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GILD positions. The advice algorithm takes into account all of Gilead Sciences' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Gilead Sciences' buy or sell advice are summarized below:
Real Value
67.13
Target Price
85.47
Hype Value
67.81
Market Value
67.31
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Gilead Sciences given historical horizon and risk tolerance towards Gilead Sciences. When Macroaxis issues a 'buy' or 'sell' recommendation for Gilead Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Gilead Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
In addition, we conduct extensive research on individual companies such as Gilead and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Execute Gilead Sciences Buy or Sell Advice

The Gilead recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Gilead Sciences. Macroaxis does not own or have any residual interests in Gilead Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Gilead Sciences' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Gilead SciencesBuy Gilead Sciences
Strong Hold

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

Fairly ValuedDetails

Odds Of Distress

Very LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Gilead Sciences has a Risk Adjusted Performance of (0.11), Jensen Alpha of (0.34), Total Risk Alpha of (0.45) and Treynor Ratio of (0.77)
Macroaxis provides unbiased trade recommendations on Gilead Sciences that should be used to complement current analysts and expert consensus on Gilead Sciences. Our advice engine determines the entity's potential to grow exclusively from the perspective of an investors' current risk tolerance and investing horizon. To make sure Gilead Sciences is not overpriced, please check out all Gilead Sciences fundamentals, including its number of shares shorted, ebitda, current ratio, as well as the relationship between the price to sales and cash per share . Given that Gilead Sciences has a price to book of 3.72 X, we strongly advise you to confirm Gilead Sciences market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Gilead Sciences Trading Alerts and Improvement Suggestions

Gilead Sciences generated a negative expected return over the last 90 days
Over 88.0% of the company shares are owned by institutional investors
On 28th of March 2024 Gilead Sciences paid $ 0.77 per share dividend to its current shareholders
Latest headline from finance.yahoo.com: CAR T-Cell Therapy for Non-Hodgkins Lymphoma Market to Showcase Significant Growth at a CAGR of 15 percent by 2032 DelveInsight

Gilead Sciences Returns Distribution Density

The distribution of Gilead Sciences' historical returns is an attempt to chart the uncertainty of Gilead Sciences' future price movements. The chart of the probability distribution of Gilead Sciences daily returns describes the distribution of returns around its average expected value. We use Gilead Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Gilead Sciences returns is essential to provide solid investment advice for Gilead Sciences.
Mean Return
-0.3
Value At Risk
-2.45
Potential Upside
1.34
Standard Deviation
1.64
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Gilead Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Gilead Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Gilead Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Gilead Sciences backward and forwards among themselves. Gilead Sciences' institutional investor refers to the entity that pools money to purchase Gilead Sciences' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Norges Bank2023-12-31
16.1 M
Bank Of New York Mellon Corp2023-12-31
15.5 M
Northern Trust Corp2023-12-31
14 M
Legal & General Group Plc0030-12-31
12.5 M
Parnassus Investments, Llc2023-12-31
12 M
Amvescap Plc.2023-12-31
11.6 M
Nuveen Asset Management, Llc2023-12-31
11.5 M
Royal Bank Of Canada2023-12-31
10.6 M
Amundi2023-12-31
10.5 M
Blackrock Inc2023-12-31
122.8 M
Vanguard Group Inc2023-12-31
111.8 M
Note, although Gilead Sciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Gilead Sciences Cash Flow Accounts

201920202021202220232024 (projected)
Change In Cash(6.3B)(5.6B)(659M)74M673M706.7M
Free Cash Flow8.3B7.5B10.8B8.3B7.4B4.2B
Depreciation1.4B1.5B2.1B2.1B2.7B2.8B
Other Non Cash Items4.6B7.8B2.1B5.1B2.2B2.3B
Capital Expenditures825M650M579M728M585M614.3M
Net Income5.4B89M6.2B4.6B5.6B3.0B
End Period Cash Flow11.6B6.0B5.3B5.4B6.1B3.7B
Change To Inventory(310M)(95M)(195M)11M(842M)(799.9M)
Change To Netincome(478M)6.5B11.4B3.5B4.0B4.2B
Investments(2.3B)11.9B(3.1B)(2.5B)(1.9B)(1.8B)
Change Receivables(218M)(1.2B)313M(406M)(466.9M)(490.2M)
Net Borrowings(2.8B)5.7B(4.8B)(1.5B)(1.4B)(1.3B)
Dividends Paid3.2B3.4B3.6B3.7B(3.8B)(3.6B)

Gilead Sciences Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Gilead Sciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Gilead Sciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Gilead stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.34
β
Beta against NYSE Composite0.41
σ
Overall volatility
1.66
Ir
Information ratio -0.22

Gilead Sciences Volatility Alert

Gilead Sciences exhibits very low volatility with skewness of -3.55 and kurtosis of 19.72. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Gilead Sciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Gilead Sciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Gilead Sciences Implied Volatility

Gilead Sciences' implied volatility exposes the market's sentiment of Gilead Sciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Gilead Sciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Gilead Sciences stock will not fluctuate a lot when Gilead Sciences' options are near their expiration.

Gilead Sciences Fundamentals Vs Peers

Comparing Gilead Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Gilead Sciences' direct or indirect competition across all of the common fundamentals between Gilead Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Gilead Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Gilead Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Gilead Sciences by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Gilead Sciences to competition
FundamentalsGilead SciencesPeer Average
Return On Equity0.26-0.31
Return On Asset0.0978-0.14
Profit Margin0.21 %(1.27) %
Operating Margin0.42 %(5.51) %
Current Valuation102.02 B16.62 B
Shares Outstanding1.25 B571.82 M
Shares Owned By Institutions88.36 %39.21 %
Number Of Shares Shorted22.57 M4.71 M
Price To Earning359.42 X28.72 X
Price To Book3.72 X9.51 X
Price To Sales3.13 X11.42 X
Revenue27.12 B9.43 B
Gross Profit21.62 B27.38 B
EBITDA7.61 B3.9 B
Net Income5.61 B570.98 M
Cash And Equivalents6.14 B2.7 B
Cash Per Share4.90 X5.01 X
Total Debt24.99 B5.32 B
Debt To Equity1.30 %48.70 %
Current Ratio1.43 X2.16 X
Book Value Per Share18.32 X1.93 K
Cash Flow From Operations8.01 B971.22 M
Short Ratio3.06 X4.00 X
Earnings Per Share4.50 X3.12 X
Price To Earnings To Growth0.42 X4.89 X
Target Price84.96
Number Of Employees18 K18.84 K
Beta0.2-0.15
Market Capitalization84.88 B19.03 B
Total Asset62.12 B29.47 B
Retained Earnings16.3 B9.33 B
Working Capital4.8 B1.48 B
Current Asset1.18 B9.34 B
Note: Acquisition by Johanna Mercier of 20086 shares of Gilead Sciences subject to Rule 16b-3 [view details]

Gilead Sciences Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Gilead . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Gilead Sciences Buy or Sell Advice

When is the right time to buy or sell Gilead Sciences? Buying financial instruments such as Gilead Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total26.7B25.2B25.0B26.2B
Total Assets68.0B63.2B62.1B65.2B

Use Investing Ideas to Build Portfolios

In addition to having Gilead Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Computers Thematic Idea Now

Computers
Computers Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Computers theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Computers Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:
Check out Gilead Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Gilead Stock analysis

When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.13)
Dividend Share
3
Earnings Share
4.5
Revenue Per Share
21.728
Quarterly Revenue Growth
(0.04)
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.